Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines

被引：0
|
作者：
Marcelo S Nacif
Andrew E Arai
Joao AC Lima
David A Bluemke
机构：
[1] Radiology and Imaging Sciences - National Institutes of Health Clinical Center,Division of Cardiology
[2] Johns Hopkins University School of Medicine,Radiology Department
[3] Universidade Federal Fluminense,Cardiovascular and Pulmonary Branch, National Heart
[4] Lung,Molecular Biomedical Imaging Laboratory
[5] and Blood Institute - National Institutes,undefined
[6] National Institute of Biomedical Imaging and Bioengineering,undefined
来源：
Journal of Cardiovascular Magnetic Resonance | / 14卷
关键词：
Contrast media; Gadolinium; Heart; Magnetic resonance imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Adverse events of after-loading high dose rate brachytherapy reported to the United States Food and Drug Administration (FDA)
    Provenzano, Destie
    Rao, Kevin
    Cifter, Gizem
    Taunk, Neil
    Fischer-Valuck, Benjamin
    Lin, Alexander
    Sarfaraz, Mehrdad
    Aghdam, Hamid
    Ojong-Ntui, Martin
    Loew, Murray H.
    Goyal, Sharad
    Rao, Yuan James
    BRACHYTHERAPY, 2021, 20 (05) : 1053 - 1061
  • [22] Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance
    McCrohon, A
    Moon, JCC
    Prasad, SK
    McKenna, WJ
    Lorenz, CH
    Coats, AJS
    Pennell, DJ
    CIRCULATION, 2003, 108 (01) : 54 - 59
  • [23] Texture-based probability mapping for automatic scar assessment in late gadolinium-enhanced cardiovascular magnetic resonance images
    Froysa, Vidar
    Berg, Goran J.
    Eftestol, Trygve
    Woie, Leik
    Orn, Stein
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2021, 8
  • [24] Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy:: A single centre experience
    Soriano, Carlos J.
    Ridocci, Francisco
    Estornell, Jordi
    Perez-Bosca, Jose L.
    Pomar, Francisco
    Trigo, Alberto
    Planas, Ana
    Nadal, Mercedes
    Jacas, Victoria
    Martinez, Vicente
    Paya, Rafael
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 116 (02) : 167 - 173
  • [25] THE UNITED-STATES FOOD AND DRUG ADMINISTRATION GUIDELINES ON AMBULATORY BLOOD-PRESSURE MONITORING
    LIPICKY, R
    JOURNAL OF HYPERTENSION, 1991, 9 : S59 - S59
  • [26] LETS PUT THE TRIALS TO A TEST: A 23 YEAR REVIEW OF UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA) RECORDS OF CARDIOVASCULAR DISEASE CLINICAL TRIALS
    Olorunfemi, Odunayo
    Ogunbayo, Gbolahan
    Ojo, Amole
    Ojo, Rebecca
    Ola, Olatunde
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2491 - 2491
  • [27] Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study
    Hammer-Hansen, Sophia
    Bandettini, W. Patricia
    Hsu, Li-Yueh
    Leung, Steve W.
    Shanbhag, Sujata
    Mancini, Christine
    Greve, Anders M.
    Kober, Lars
    Thune, Jens Jakob
    Kellman, Peter
    Arai, Andrew E.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2016, 17 (01) : 76 - 84
  • [28] Delayed gadolinium-enhanced magnetic resonance imaging of cartilage in knee osteoarthritis - Findings at different radiographic stages of disease and relationship to malalignment
    Williams, A
    Sharma, L
    McKenzie, CA
    Prasad, PV
    Burstein, D
    ARTHRITIS AND RHEUMATISM, 2005, 52 (11): : 3528 - 3535
  • [29] The United States Food and Drug Administration (FDA) regulatory response to combat neglected tropical diseases (NTDs): A review
    Mukherjee, Sanjana
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (01):
  • [30] The United States Food And Drug Administration (FDA) set review timeline for Bydureon, the once weekly formulation of Exenatide
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2010, 12 (07): : 638 - 638
12345